These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 37979586)

  • 1. EGFR promotes ALKBH5 nuclear retention to attenuate N6-methyladenosine and protect against ferroptosis in glioblastoma.
    Lv D; Zhong C; Dixit D; Yang K; Wu Q; Godugu B; Prager BC; Zhao G; Wang X; Xie Q; Bao S; He C; Heiland DH; Rosenfeld MG; Rich JN
    Mol Cell; 2023 Dec; 83(23):4334-4351.e7. PubMed ID: 37979586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High expression of AlkB homolog 5 suppresses the progression of non-small cell lung cancer by facilitating ferroptosis through m6A demethylation of SLC7A11.
    Huang Z; Lin G; Hong Y; Weng L; Zhu K; Zhuang W
    Environ Toxicol; 2024 Jul; 39(7):4035-4046. PubMed ID: 38642004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ALKBH5 Modulates Asthma Progression by Downregulating N6-methyladenosine Methylation.
    Fan X; Wei C; Han Y
    Iran J Allergy Asthma Immunol; 2024 Apr; 23(2):211-219. PubMed ID: 38822515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ALKBH5 activates FAK signaling through m6A demethylation in
    Sun R; Yuan L; Jiang Y; Wan Y; Ma X; Yang J; Sun G; Zhou S; Wang H; Qiu J; Zhang L; Cheng W
    Theranostics; 2023; 13(2):833-848. PubMed ID: 36632222
    [No Abstract]   [Full Text] [Related]  

  • 5. K235 acetylation couples with PSPC1 to regulate the m
    Zhang XL; Chen XH; Xu B; Chen M; Zhu S; Meng N; Wang JZ; Zhu H; Chen D; Liu JB; Yan GR
    Nat Commun; 2023 Jun; 14(1):3815. PubMed ID: 37369679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A LATS2 and ALKBH5 positive feedback loop supports their oncogenic roles.
    Cao L; Han R; Zhao Y; Qin X; Li Q; Xiong H; Kong Y; Liu Z; Li Z; Dong F; Li T; Zhao X; Lei L; Zhao Q; Liu D; Wang B; Wu X
    Cell Rep; 2024 Apr; 43(4):114032. PubMed ID: 38568805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. m
    Zhang S; Zhao BS; Zhou A; Lin K; Zheng S; Lu Z; Chen Y; Sulman EP; Xie K; Bögler O; Majumder S; He C; Huang S
    Cancer Cell; 2017 Apr; 31(4):591-606.e6. PubMed ID: 28344040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNA demethylase ALKBH5 regulates hypopharyngeal squamous cell carcinoma ferroptosis by posttranscriptionally activating NFE2L2/NRF2 in an m
    Ye J; Chen X; Jiang X; Dong Z; Hu S; Xiao M
    J Clin Lab Anal; 2022 Jul; 36(7):e24514. PubMed ID: 35689537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioactive peptide inhibits acute myeloid leukemia cell proliferation by downregulating ALKBH5-mediated m
    Zhang L; Su X
    Cell Oncol (Dordr); 2022 Jun; 45(3):355-365. PubMed ID: 35579750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RNA demethylase ALKBH5 in cancer: from mechanisms to therapeutic potential.
    Qu J; Yan H; Hou Y; Cao W; Liu Y; Zhang E; He J; Cai Z
    J Hematol Oncol; 2022 Jan; 15(1):8. PubMed ID: 35063010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of two novel ALKBH5 selective inhibitors that exhibit uncompetitive or competitive type and suppress the growth activity of glioblastoma multiforme.
    Takahashi H; Hase H; Yoshida T; Tashiro J; Hirade Y; Kitae K; Tsujikawa K
    Chem Biol Drug Des; 2022 Jul; 100(1):1-12. PubMed ID: 35384315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone-derived mesenchymal stem cells alleviate compression-induced apoptosis of nucleus pulposus cells by N6 methyladenosine of autophagy.
    Li G; Song Y; Liao Z; Wang K; Luo R; Lu S; Zhao K; Feng X; Liang H; Ma L; Wang B; Ke W; Yin H; Zhan S; Li S; Wu X; Zhang Y; Yang C
    Cell Death Dis; 2020 Feb; 11(2):103. PubMed ID: 32029706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. m
    Nagaki Y; Motoyama S; Yamaguchi T; Hoshizaki M; Sato Y; Sato T; Koizumi Y; Wakita A; Kawakita Y; Imai K; Nanjo H; Watanabe H; Imai Y; Minamiya Y; Kuba K
    Genes Cells; 2020 Aug; 25(8):547-561. PubMed ID: 32449584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The m6A demethylase ALKBH5 promotes tumor progression by inhibiting RIG-I expression and interferon alpha production through the IKKε/TBK1/IRF3 pathway in head and neck squamous cell carcinoma.
    Jin S; Li M; Chang H; Wang R; Zhang Z; Zhang J; He Y; Ma H
    Mol Cancer; 2022 Apr; 21(1):97. PubMed ID: 35395767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ALKBH5 targets ACSL4 mRNA stability to modulate ferroptosis in hyperbilirubinemia-induced brain damage.
    Zhou J; Tang J; Zhang C; Li G; Lin X; Liao S; Luo J; Yu G; Zheng F; Guo Z; Shao W; Hu H; Xu L; Wu S; Li H
    Free Radic Biol Med; 2024 Aug; 220():271-287. PubMed ID: 38734267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ALKBH5 Promotes Multiple Myeloma Tumorigenicity through inducing m
    Yu T; Yao L; Yin H; Teng Y; Hong M; Wu Q
    Int J Biol Sci; 2022; 18(6):2235-2248. PubMed ID: 35414790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ALKBH5 suppresses malignancy of hepatocellular carcinoma via m
    Chen Y; Zhao Y; Chen J; Peng C; Zhang Y; Tong R; Cheng Q; Yang B; Feng X; Lu Y; Xie H; Zhou L; Wu J; Zheng S
    Mol Cancer; 2020 Aug; 19(1):123. PubMed ID: 32772918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of m6A mRNA modification by DNA hypermethylated ALKBH5 aggravates the oncological behavior of KRAS mutation/LKB1 loss lung cancer.
    Zhang D; Ning J; Okon I; Zheng X; Satyanarayana G; Song P; Xu S; Zou MH
    Cell Death Dis; 2021 May; 12(6):518. PubMed ID: 34016959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epitranscriptomic editing of the RNA N6-methyladenosine modification by dCasRx conjugated methyltransferase and demethylase.
    Xia Z; Tang M; Ma J; Zhang H; Gimple RC; Prager BC; Tang H; Sun C; Liu F; Lin P; Mei Y; Du R; Rich JN; Xie Q
    Nucleic Acids Res; 2021 Jul; 49(13):7361-7374. PubMed ID: 34181729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N6-methyladenosine demethylase ALKBH5 suppresses colorectal cancer progression potentially by decreasing PHF20 mRNA methylation.
    Zhang Z; Wang L; Zhao L; Wang Q; Yang C; Zhang M; Wang B; Jiang K; Ye Y; Wang S; Shen Z
    Clin Transl Med; 2022 Aug; 12(8):e940. PubMed ID: 35979628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.